-
Heart Health: Researchers Develop AI Tool That Predicts Fatal Heart Rhythm With 80% Accuracy
28 Mar 2024 13:47 GMT
… team of researchers have developed an artificial intelligence … abnormalities, thyroid disorders, medication side effects, and lifestyle … conditions such as atrial fibrillation or ventricular fibrillation. … the life-saving treatment with an implantable …
-
Milestone Pharmaceuticals Announces Resubmission of New Drug Application for Etripamil for Treatment in Paroxysmal Supraventricular Tachycardia
28 Mar 2024 11:00 GMT
… Food and Drug Administration (FDA) for etripamil … procedures. About Atrial Fibrillation with Rapid … trial for the treatment of patients with AFib-RVR. About Milestone Pharmaceuticals Milestone Pharmaceuticals … biopharmaceutical product development and clinical …
-
Racial and Ethnic Differences in Initiation and Discontinuation of Antiarrhythmic Medications in Management of Atrial Fibrillation
27 Mar 2024 10:58 GMT
… medication for management of atrial fibrillation. … atrial fibrillation treated with catheter ablation vs antiarrhythmic drugs … management of atrial fibrillation developed in collaboration … differences in atrial fibrillation symptoms, treatment patterns, and …
-
Medtronic's Latest Generation Of Transcatheter Aortic Valve Replacement Implant Passes FDA's Muster, Shares Gain
27 Mar 2024 18:30 GMT
Wednesday, the FDA approved Medtronic … FDA approved Medtronic’s PulseSelect Pulsed Field Ablation System for the treatment … of both paroxysmal and persistent atrial fibrillation, an … first PFA technology with FDA breakthrough designation to …
-
Biosense Webster Announces FDA Submission for Approval of the Varipulse Platform
27 Mar 2024 14:39 GMT
… FDA for their Varipulse Platform that treats paroxysmal atrial fibrillation … Trial
Trial Name: Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation … Webster is developing to meet … with symptomatic drug refractory paroxysmal …
-
Biosense Webster Submits Application to U.S. FDA Seeking Approval of the VARIPULSE™ Platform for the Treatment of Paroxysmal Atrial Fibrillation
25 Mar 2024 15:18 GMT
… Webster is developing to … identify, treat, and deliver … atrial fibrillation: the randomized controlled atrial fibrillation progression trial … fda-seeking-approval-of-the-varipulse-platform-for-the-treatment-of-paroxysmal-atrial-fibrillation …
-
'Much safer for patients': New heart procedure at Nebraska Medicine to treat AFib
27 Mar 2024 04:09 GMT
… FDA in December 2023, pulsed-field ablation is a procedure to treat atrial fibrillation … , but it is treatable. Treatment can mean medication or, in many cases … , but it is treatable. Treatment can mean medication or, in many cases …
-
Human induced pluripotent stem cell-derived cardiomyocytes to study inflammation-induced diastolic dysfunction
28 Mar 2024 17:01 GMT
… artery disease, hyperlipidemia, and atrial fibrillation. Although beta blockers ( … circulating drug concentration in patients receiving these medications … various ART drugs. (A) Decay time after treatment with TNF … mechanism for the development of the disease. …
-
J&J files for FDA approval of Varipulse pulsed field ablation platform
26 Mar 2024 17:38 GMT
… , filed for Food and Drug Administration approval using data from … add billions of dollars to atrial fibrillation (AFib) ablation sales in … The company started a clinical trial of its PFA device early … , Duato said, and is developing a range of catheters to …
-
Sirnaomics Announces 2023 Annual Results
28 Mar 2024 15:54 GMT
… the Food and Drug Administration (FDA) sponsored by RNAimmune … -stage development of STP705 for the treatment of … requiring anticoagulation, including atrial fibrillation, pulmonary embolism, deep … discovery and development of innovative drugs for indications …